Trial Profile
Phase II trial of LB-100 plus docetaxel in patients with solid tumours
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 23 Mar 2015
Price :
$35
*
At a glance
- Drugs LB 100 (Primary) ; Docetaxel
- Indications Solid tumours
- Focus Therapeutic Use
- Sponsors Lixte Biotechnology Holdings
- 23 Mar 2015 New trial record